Baten

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Baten

Property Description
Active ingredient Fluconazole
Pharmacological class Triazole Antifungal Agent
Forms Tablet, Hard Capsule, Intravenous Solution
Origin Synthetic
Purpose Systemic control of fungal infections

What Type of Medicine is Baten and What is its Composition?

Baten is a synthetic single-ingredient pharmaceutical product defined by its active substance, Fluconazole, which is classified as an Antifungal agent belonging to the triazole antifungal group. The drug is recognized as a prescription-only medicine (Rx), underscoring its therapeutic role.

This medicine is intended for systemic treatment, meaning it is formulated to be absorbed into the bloodstream to act throughout the body. Fluconazole is clinically recognized for its high oral bioavailability, ensuring that the medicine is efficiently absorbed from the gastrointestinal tract. Baten is manufactured in multiple dosage forms to support flexible administration, including solid preparations for oral use (the tablet and hard gelatin capsule) and a sterile solution for intravenous use.


What is the General Purpose of Baten?

The general purpose of Baten is to limit the viability and systemic spread of fungal organisms, thereby helping to control and resolve widespread infections. Baten achieves its effect by selectively targeting an enzyme (lanosterol 14alpha-demethylase) that is essential for the fungus to build and maintain its cell membrane.

This precise physiological action prevents the fungus from properly producing ergosterol, a crucial structural component of the fungal cell wall. This inhibition establishes a primarily fungistatic effect, which stops the organism from growing and reproducing effectively and allows the body's natural defenses to take control of the infection. Baten is fundamental in providing comprehensive anti-fungal action across different tissues and organs.

Regulatory References

  1. DailyMed Fluconazole

What side effects are possible with Baten?

Possible Side Effects and Safety Information

Baten's (Fluconazole) safety profile is officially documented and categorized according to the frequency and system organ class affected, based on regulatory standards. The adverse reactions range from very common to rare events, as established in prescribing information by authorities like the FDA and EMA.

Classification of Documented Adverse Reactions

Frequency Tier Examples of Officially Listed Effects
Very Common (ge 1/10) Headache
Common (ge 1/100 to < 1/10) Nausea, vomiting, diarrhea, abdominal pain, rash, increases in liver enzymes (ALT, AST).
Rare (ge 1/10,000 to < 1/1,000) Anaphylaxis, agranulocytosis, serious cutaneous reactions (Stevens-Johnson syndrome, Toxic Epidermal Necrolysis), and cardiac events like QT prolongation and Torsade de pointes.

Serious Safety Considerations

The official label explicitly identifies the potential for serious adverse reactions, including hepatic failure and other forms of severe liver toxicity, which have been reported to occur with both short-term and long-term exposure. Additionally, rare but serious effects on the cardiovascular system, such as QT interval prolongation and the resulting risk of Torsade de pointes, are documented.

Population-Specific Notes

The drug is cleared primarily by the kidneys. Therefore, regulatory documents advise that safety considerations are necessary for individuals with renal impairment, as well as elderly patients, whose disposition of the drug is often affected by age-related decline in kidney function. The co-administration of Baten with other medicines known to prolong the QT interval is restricted, reflecting a major safety limitation.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents for Baten (Fluconazole) define the risks and required actions in the event of an overdose. Immediate medical attention is required when overdose is suspected due to the risk of serious complications.

Documented Overdose Manifestations

Overdose has been officially associated with specific central nervous system (CNS) manifestations, including hallucination and paranoid behavior. Furthermore, severe exposure carries a documented risk of life-threatening cardiotoxicity requiring urgent attention. This risk includes QT prolongation on the electrocardiogram and the potential for a severe heart rhythm disturbance known as Torsade de pointes (TdP). The management of such events is critical and necessitates continuous observation.

Emergency Actions and Management

Category Regulatory Statement
Urgent Requirement Immediate medical attention must be sought to institute appropriate symptomatic treatment and supportive measures.
Antidote No specific antidote is known for this overdose.
Procedural Management Gastric lavage may be considered if clinically warranted. As the drug is primarily eliminated by renal excretion, hemodialysis is an established procedure for clearance. It is documented to reduce the plasma concentration by approximately 50% over a three-hour session, which is a key factor in managing severe overdose, particularly in cases of reduced renal function.

Summary

The regulatory profile emphasizes that due to the risk of severe CNS effects and life-threatening cardiac involvement, any suspected overdose requires prompt clinical intervention. Management relies on immediate supportive care and the procedural reduction of drug concentration.

Therapeutic Uses of Baten

Baten is commonly used to help manage severe fungal infections by providing supportive systemic relief across multiple organ systems. The medicine is generally applied across a range of conditions that cause significant symptoms and is relevant for managing conditions associated with significant systemic burden.

The medicine is commonly used to help with conditions that include Systemic Candidiasis (bloodstream and internal organs), Cryptococcal Meningitis (central nervous system), Esophageal Candidiasis (throat), and acute or recurrent Vaginal Candidiasis. It provides support that helps ease the overall symptom burden, and may assist with the body's efforts to control the widespread fungal burden, which helps maintain a sense of stability during acute episodes.

Baten is also applied in clinical settings that involve acute or unstable symptom patterns by offering essential prophylactic support for patients with compromised immunity. This preventative application may assist with the body's efforts to manage symptomatic burden, and is relevant when supportive symptom management is appropriate in high-risk contexts.


Quick Fact: Use in Symptomatic Discomfort

Baten is commonly used to help with symptoms related to inflammatory or irritative states, such as intense itching and burning from genitourinary infections or painful swallowing (dysphagia) from mucosal infections. The therapeutic benefit is applied in addressing symptom clusters that interfere with daily functioning, which supports functional stability during symptomatic phases.

Regulatory References

  1. Fluconazole: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Baten?

The eligibility for Baten (Fluconazole) is strictly governed by official regulatory criteria, which define populations for absolute prohibition and conditional use.

Absolute Contraindications (Must Not Use):

  • Patients with documented hypersensitivity to fluconazole, related azole antifungals, or any of the product's excipients.
  • Patients concurrently taking medicines that prolong the QT interval and are metabolized by the CYP3A4 enzyme (e.g., pimozide, quinidine, erythromycin).

Conditional or Restricted Use:

  • Renal Impairment: Use is restricted, as a dose reduction is required in patients with impaired renal function (creatinine clearance leq 50 mL/min).
  • Hepatic Impairment: Must be administered with caution due to limited data on liver dysfunction.
  • Cardiovascular Conditions: Caution is mandatory for those with pre-existing heart rhythm problems or electrolyte abnormalities.

Age and Reproductive Limitations:

  • Pediatrics: Use is permitted for systemic infections; however, safety and efficacy for genital candidiasis is not established.
  • Older Adults (Geriatric): Single-dose use is not recommended for vaginal candidiasis in women aged over 60 years.
  • Pregnancy: High-dose or prolonged use is prohibited, except for potentially life-threatening infections. A single standard dose is permitted during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Drug interactions occur when a medicine's effects are altered by the co-administration of other medicinal products, including prescription drugs, over-the-counter medicines, herbal supplements, or specific foods. Such alterations can potentially change the concentration of Baten in the body, which could result in reduced effectiveness or an increased risk of side effects.

Authoritative regulatory documents typically classify interactions based on their severity (e.g., contraindicated, use-with-caution) and their underlying mechanism, such as effects on drug metabolism via liver enzymes (like the Cytochrome P450 system) or drug transporters.

Due to the nature of drug development, the full range of potential interactions for any medicine requires comprehensive evaluation. Patients should ensure their healthcare provider is aware of all products they are currently using to allow for a full review of any potential risks and to manage the timing or dosage of Baten and other treatments as necessary.

Interaction Type General Context of Concern
Pharmacokinetic Interactions that affect the absorption, distribution, metabolism, or excretion of Baten.
Pharmacodynamic Interactions where Baten and another medicine affect the same biological target or pathway, potentially leading to additive or opposing effects.

All individuals should consult the official patient information leaflet and discuss their complete medication profile with a pharmacist or physician, particularly before starting any new therapy, to understand any specific interaction constraints or necessary monitoring for Baten.

Mechanism of Action

Selective Inhibition of Fungal Enzyme (L14DM)

The drug's mechanism involves a molecular interaction where it acts as a non-competitive enzyme inhibitor of lanosterol 14α-demethylase ( L14 DM), a specific cytochrome P450 enzyme in the fungal endoplasmic reticulum. By binding to the heme iron within the enzyme's active site, Baten blocks this essential step in the fungal sterol biosynthesis pathway.


Disruption of Cell Structure Leading to Fungistasis

The blocked enzyme function initiates a mechanistic cascade: ergosterol (the crucial structural sterol) is depleted, while toxic 14-methylated sterols accumulate within the fungal plasma membrane. This combined effect causes destabilization and increased permeability of the fungal cell membrane, resulting in the failure of the fungus to maintain its structure, grow, and divide. This limitation on proliferation establishes a fungistatic state, which is the core physiological change that dictates the drug's effect on fungal population density.

Dosage and Administration Information

The medicine Baten (Fluconazole) is administered through two official routes: orally via tablets, capsules, or an oral suspension, and intravenously using a sterile solution for infusion. The daily dose is functionally equivalent whether delivered orally or intravenously due to the drug's high bioavailability. Oral forms of Baten can be taken with or without food, as absorption is not significantly affected by meal timing.

Dosing Schedule and Frequency

The standard protocol often involves a loading dose on the first day, typically twice the recommended maintenance dose, which is designed to achieve steady-state drug levels rapidly. Following this initial dose, the medicine is generally taken once daily (qDay). Maintenance doses vary widely based on the specific condition, ranging from 50 mg to 400 mg daily, with specific severe systemic conditions authorizing doses up to 800 mg. The total length of use can range from a single 150 mg dose up to several months of maintenance therapy.

Procedural Constraints and Adjustments

Specific instructions govern the use of Baten in certain populations and administration settings:

  • Renal Function: A critical procedural step is the adjustment of dosage for patients with reduced kidney function. If creatinine clearance is measured at le 50 mL/min, the subsequent daily maintenance dose must be reduced by 50% after the initial loading dose. Patients undergoing hemodialysis are instructed to receive the full dose immediately after each dialysis session.
  • Pediatric Dosing: In infants, a weight-based dosing regimen is mandated, and neonates require an extended dosing interval, such as every 72 hours initially, to account for developmental pharmacokinetics.
  • IV Administration: Intravenous delivery requires a controlled rate, with the solution infused at a maximum rate of 10 mL/minute.

Recent Clinical Evidence

Research evidence / Overview of studies for Baten (Fluconazole)


Evidence for Systemic Fungal Infections

Research examining the use of Baten for Systemic Candidiasis has included Randomized Controlled Trials and comparison studies. Researchers have monitored specific outcomes, such as the time needed for fungal clearance from the bloodstream or tissue culture (mycological clearance) and overall patient survival. The research examined how the measured outcomes were assessed against other antifungal agents in specific settings. The findings describe patterns observed in these studies, where measured outcomes related to functional imbalance were assessed over defined time intervals, typically several weeks.

Evidence for Central Nervous System Infections

Baten was studied for the management of Cryptococcal Meningitis, primarily in immunocompromised patients. Research has explored its use alone and in combination with other treatments, and as long-term suppressive therapy to prevent symptoms from returning. Key outcomes monitored included the speed of fungal clearance from the cerebrospinal fluid (CSF sterilization) and assessments of neurological stability. The evidence also shows that Baten was observed in long-term studies, and researchers monitored for recurrence and outcomes describing episodic or acute changes after initial observation periods.


Evidence for Mucosal and Genitourinary Infections

Research has included short-term RCTs that examined Baten for acute and recurrent forms of Oropharyngeal/Esophageal Candidiasis and Vaginal Candidiasis. Studies monitored outcomes related to physical discomfort, such as the resolution of symptoms (clinical cure), and the clearance of the fungus from the site (mycological cure). For acute Vaginal Candidiasis, studies exploring short-term symptom changes report how symptoms evolved in the observed populations when comparing single-dose oral Baten to other forms of treatment.


What Research Questions and Uncertainties Remain

Despite extensive research, certainty remains low in several areas of Baten's use. A major focus of ongoing research is the growing concern over the potential for certain fungal species to develop reduced susceptibility. Comparative evidence is lacking in some areas when assessing Baten against newer classes of antifungal agents. Additionally, data for certain groups remain insufficient, notably during pregnancy, where the research landscape notes that alternative approaches are often observed due to the lack of extensive research and potential for uncertainty.

Key Studies & References

  1. Fluconazole: MedlinePlus Drug Information
  2. National Institute for Health and Care Excellence (NICE) Guideline: Antimicrobial prescribing guideline [NG176] - Systemic antifungals

Frequently Asked Questions (FAQ)

Common questions about Baten (FAQ)


Q: What is the main reason Baten is prescribed?

According to official product information, Baten is prescribed to control and treat various fungal infections throughout the body. These approved uses commonly include treating cryptococcal meningitis and different forms of candidiasis, such as oral thrush, esophageal infections, and vaginal infections.


Q: Are there different strengths of Baten available?

Official documents state that Baten tablets are manufactured in multiple strengths to accommodate varying treatment needs. Common available tablet strengths are typically listed as 50 mg, 100 mg, 150 mg, and 200 mg.


Q: What is the difference between the active ingredient and the inactive ingredients in Baten?

The active ingredient, Fluconazole, is the substance responsible for treating the fungal infection. Inactive ingredients, known as excipients, are added to aid in the medicine's form, stability, and proper delivery, and do not provide a therapeutic action.


Q: How quickly does Baten usually start to have an effect?

Studies and official information indicate that the time it takes to notice an effect is dependent on the type and severity of the infection. For less severe infections, a reduction in symptoms may start to be noticed in some patients within one to two days, but treatment for more extensive infections can require one to two weeks before the full effect is established.


Q: How long does the effect of Baten last after taking it?

Pharmacological studies indicate the drug has a long half-life. This means its concentration in the bloodstream decays slowly, supporting its typical once-daily dosing.


Q: What happens if I miss a dose of Baten?

Standard procedural guidance for a missed dose is included in the patient information leaflet. This typically addresses when to take a remembered dose and when to skip it to avoid doubling the amount.


Q: Is it normal for some people to not notice an effect from Baten right away?

Yes, this can be normal. While the medicine begins working right away, symptom relief is often gradual. The full therapeutic effect may not be fully noticeable until several days or a week after starting the treatment course, especially for complex infections.


Q: Does Baten cause weight gain or weight loss for some users?

Weight loss is not typically listed as a common or frequent adverse effect in official documents. However, it has been reported in rare instances as a symptom associated with serious safety considerations, specifically problems with the adrenal glands.


Q: Is Baten known to affect sleep patterns?

Regulatory-related information reports that Baten is known to potentially affect sleep patterns. Documented adverse effects listed in official sources include both insomnia (difficulty sleeping) and somnolence (drowsiness).


Q: What are the rules regarding driving or operating machinery while using Baten?

Due to the potential for adverse reactions like dizziness or drowsiness, official patient information advises caution. It is generally recommended to refrain from driving or operating machinery until the patient knows how Baten affects their body.


Q: What should I do if I notice a change in how I feel after starting Baten?

If you notice any unexpected or concerning changes in how you feel, or if your infection symptoms seem to worsen, official guidance advises contacting a healthcare provider or pharmacist promptly for evaluation.


Q: Is Baten known to interact with common pain relievers like ibuprofen?

Regulatory documents confirm that Baten is known to interact with certain nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. This interaction can slow the body's clearance of the pain reliever, potentially leading to increased effects or risk of side effects.


Q: Can Baten be crushed, chewed, or split?

Regulatory guidance for the oral tablet form advises that the medicine should be swallowed whole. The official instructions typically state that tablets should not be crushed, broken, or chewed.


Q: Can women who are planning to become pregnant use Baten?

Official information discusses the need for effective contraception for women of childbearing potential during treatment and for a period afterward, due to the risk of exposure during the early stages of pregnancy.


Q: Are there any known interactions between Baten and alcohol?

Although a direct drug-alcohol interaction is not consistently documented, official sources suggest caution. Patients should discuss the potential effects of combining Baten with alcohol with a healthcare professional, as both may worsen common side effects like headache and dizziness, and both may stress the liver.


Q: Why is Baten sometimes referred to by different names internationally?

Baten (Fluconazole) is the generic name for the active drug substance. Internationally, the drug is known and sold under numerous different brand names, such as Diflucan, which vary by country and manufacturer.


Q: Does Baten interact with caffeine?

Official documents indicate that Baten can interact with caffeine by potentially inhibiting the rate at which the body clears it. This could result in increased effects of caffeine, such as nervousness or difficulty sleeping.


Q: Are there any specific foods or drinks mentioned in official documents that interact with Baten?

Official documents indicate that Baten may slow down the body’s clearance of caffeine, which is found in certain foods and drinks. This can potentially lead to an increase in caffeine’s effects, such as feelings of nervousness or difficulty sleeping.


Q: Do I need to take Baten at a specific time of day?

Baten is generally prescribed to be taken once daily ( qDay). Regulatory guidance recommends taking the dose at approximately the same time each day to help maintain consistent drug levels in the bloodstream.


Q: Has there been any recent research or new findings about Baten?

Studies and medical literature continue to examine Baten’s therapeutic role. Current research focuses on areas such as emerging drug resistance mechanisms in certain fungal species and the comparative effectiveness against newer antifungal agents.


Q: Are there any blood tests or monitoring generally required while taking Baten?

Regulatory documents state that ongoing monitoring may be required, especially for patients taking certain other medicines with a narrow therapeutic window. Due to the documented risk of liver toxicity, liver function tests may also be performed.


Q: Does Baten require a special prescription or monitoring program?

Baten is classified as a prescription-only medicine (Rx) by regulatory bodies. While it does not typically require a specific, formalized patient registry program, ongoing medical monitoring is often necessary, especially given the documented risks of liver and cardiac effects.


Q: What is the role of the patient in monitoring their own progress with Baten?

The patient's role involves strict adherence to the prescribed regimen and being vigilant for any documented adverse effects. Patients are generally advised to promptly report any concerning changes or worsening symptoms to their healthcare provider.


Q: Is the cost of Baten generally covered by insurance?

As a commonly used generic medicine, Baten (Fluconazole) is typically covered by most commercial health insurance, Medicare, and Medicaid plans. Coverage and specific costs, however, will vary based on the details of the patient's individual plan.


Q: What common illnesses should be reported to a prescriber while taking Baten?

Regulatory guidance recommends informing your prescriber of any new medical conditions or illnesses that arise while taking Baten. This is especially important for conditions that affect the kidneys or liver, as these organs are key to drug processing and may require dosage adjustments.

How should Baten be stored and disposed of?

How to Store and Dispose of Baten (Fluconazole)

Storage and disposal must strictly follow the official instructions provided in regulatory labeling to maintain product stability and safety.

Storage Requirements

The storage temperature varies by dosage form. Tablets and dry powder must be stored below 30 C (86 F). The reconstituted oral suspension must be stored between 5 C and 30 C (41 F and 86 F), and must be discarded after 14 days. All forms must be kept out of the reach and sight of children, protected from freezing, and stored in the original container with the cap tightly closed.

Disposal Requirements

Disposal of unused or expired medicine must be done according to local and national regulations. The product must not be disposed of via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Baten found in:

A-Z Index: